nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—HRH1—atherosclerosis	0.398	1	CbGaD
Perphenazine—CYP2B6—Simvastatin—atherosclerosis	0.0326	0.0916	CbGbCtD
Perphenazine—CYP2C8—Simvastatin—atherosclerosis	0.0247	0.0694	CbGbCtD
Perphenazine—CYP2C8—Pravastatin—atherosclerosis	0.0242	0.0679	CbGbCtD
Perphenazine—CYP2C8—Lovastatin—atherosclerosis	0.0242	0.0679	CbGbCtD
Perphenazine—CYP2C19—Rosuvastatin—atherosclerosis	0.0223	0.0626	CbGbCtD
Perphenazine—CYP2C19—Simvastatin—atherosclerosis	0.0207	0.0582	CbGbCtD
Perphenazine—CYP2C19—Lovastatin—atherosclerosis	0.0203	0.0569	CbGbCtD
Perphenazine—CYP2D6—Niacin—atherosclerosis	0.0199	0.056	CbGbCtD
Perphenazine—CYP2C9—Rosuvastatin—atherosclerosis	0.0185	0.052	CbGbCtD
Perphenazine—CYP2C9—Simvastatin—atherosclerosis	0.0172	0.0484	CbGbCtD
Perphenazine—CYP2C9—Lovastatin—atherosclerosis	0.0169	0.0473	CbGbCtD
Perphenazine—CYP2C9—Pravastatin—atherosclerosis	0.0169	0.0473	CbGbCtD
Perphenazine—CYP2D6—Simvastatin—atherosclerosis	0.0157	0.0442	CbGbCtD
Perphenazine—CYP2D6—Lovastatin—atherosclerosis	0.0154	0.0433	CbGbCtD
Perphenazine—CYP2D6—Pravastatin—atherosclerosis	0.0154	0.0433	CbGbCtD
Perphenazine—CYP3A4—Rosuvastatin—atherosclerosis	0.0108	0.0303	CbGbCtD
Perphenazine—CYP3A4—Ezetimibe—atherosclerosis	0.0108	0.0303	CbGbCtD
Perphenazine—CYP3A4—Simvastatin—atherosclerosis	0.01	0.0281	CbGbCtD
Perphenazine—CYP3A4—Lovastatin—atherosclerosis	0.0098	0.0275	CbGbCtD
Perphenazine—CYP3A4—Pravastatin—atherosclerosis	0.0098	0.0275	CbGbCtD
Perphenazine—Lenticular opacities—Lovastatin—atherosclerosis	0.00486	0.0459	CcSEcCtD
Perphenazine—Lenticular opacities—Simvastatin—atherosclerosis	0.00455	0.0429	CcSEcCtD
Perphenazine—Lenticular opacities—Pravastatin—atherosclerosis	0.00411	0.0388	CcSEcCtD
Perphenazine—HTR2A—arteriole—atherosclerosis	0.00282	0.0942	CbGeAlD
Perphenazine—HTR7—vein—atherosclerosis	0.00269	0.0901	CbGeAlD
Perphenazine—Lupus erythematosus—Lovastatin—atherosclerosis	0.00262	0.0247	CcSEcCtD
Perphenazine—Lupus erythematosus—Simvastatin—atherosclerosis	0.00245	0.0231	CcSEcCtD
Perphenazine—Lupus erythematosus—Pravastatin—atherosclerosis	0.00221	0.0209	CcSEcCtD
Perphenazine—Ache—Lovastatin—atherosclerosis	0.00211	0.02	CcSEcCtD
Perphenazine—Ache—Simvastatin—atherosclerosis	0.00198	0.0187	CcSEcCtD
Perphenazine—Ache—Pravastatin—atherosclerosis	0.00179	0.0169	CcSEcCtD
Perphenazine—Systemic lupus erythematosus—Lovastatin—atherosclerosis	0.00176	0.0166	CcSEcCtD
Perphenazine—HTR2A—vein—atherosclerosis	0.00168	0.0562	CbGeAlD
Perphenazine—Systemic lupus erythematosus—Simvastatin—atherosclerosis	0.00165	0.0156	CcSEcCtD
Perphenazine—Systemic lupus erythematosus—Pravastatin—atherosclerosis	0.00149	0.0141	CcSEcCtD
Perphenazine—Blood disorder—Rosuvastatin—atherosclerosis	0.00138	0.013	CcSEcCtD
Perphenazine—Laryngeal oedema—Niacin—atherosclerosis	0.00131	0.0123	CcSEcCtD
Perphenazine—CALM2—artery—atherosclerosis	0.00113	0.0377	CbGeAlD
Perphenazine—CALM1—artery—atherosclerosis	0.00112	0.0376	CbGeAlD
Perphenazine—HTR2A—hindlimb—atherosclerosis	0.00112	0.0373	CbGeAlD
Perphenazine—Glaucoma—Niacin—atherosclerosis	0.00111	0.0105	CcSEcCtD
Perphenazine—Jaundice cholestatic—Lovastatin—atherosclerosis	0.00111	0.0105	CcSEcCtD
Perphenazine—Cholestasis—Niacin—atherosclerosis	0.0011	0.0104	CcSEcCtD
Perphenazine—HTR7—artery—atherosclerosis	0.0011	0.0367	CbGeAlD
Perphenazine—Jaundice cholestatic—Simvastatin—atherosclerosis	0.00104	0.00981	CcSEcCtD
Perphenazine—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00103	0.00973	CcSEcCtD
Perphenazine—HTR2A—appendage—atherosclerosis	0.000957	0.032	CbGeAlD
Perphenazine—Hepatocellular injury—Ezetimibe—atherosclerosis	0.000957	0.00904	CcSEcCtD
Perphenazine—Jaundice cholestatic—Niacin—atherosclerosis	0.000953	0.00901	CcSEcCtD
Perphenazine—CALM2—endothelium—atherosclerosis	0.000953	0.0319	CbGeAlD
Perphenazine—CALM1—endothelium—atherosclerosis	0.000948	0.0317	CbGeAlD
Perphenazine—Jaundice cholestatic—Pravastatin—atherosclerosis	0.000939	0.00887	CcSEcCtD
Perphenazine—HTR7—endothelium—atherosclerosis	0.000927	0.031	CbGeAlD
Perphenazine—Hepatocellular injury—Simvastatin—atherosclerosis	0.000912	0.00862	CcSEcCtD
Perphenazine—CALM2—blood vessel—atherosclerosis	0.000879	0.0294	CbGeAlD
Perphenazine—CALM1—blood vessel—atherosclerosis	0.000875	0.0293	CbGeAlD
Perphenazine—Gynaecomastia—Lovastatin—atherosclerosis	0.000873	0.00824	CcSEcCtD
Perphenazine—HTR7—blood vessel—atherosclerosis	0.000854	0.0286	CbGeAlD
Perphenazine—Dermatitis contact—Niacin—atherosclerosis	0.000828	0.00782	CcSEcCtD
Perphenazine—Hepatocellular injury—Pravastatin—atherosclerosis	0.000825	0.00779	CcSEcCtD
Perphenazine—Gynaecomastia—Simvastatin—atherosclerosis	0.000816	0.00771	CcSEcCtD
Perphenazine—Photosensitivity—Lovastatin—atherosclerosis	0.000806	0.00762	CcSEcCtD
Perphenazine—Photosensitivity—Ezetimibe—atherosclerosis	0.000791	0.00747	CcSEcCtD
Perphenazine—Haemolytic anaemia—Lovastatin—atherosclerosis	0.000784	0.00741	CcSEcCtD
Perphenazine—Urine output increased—Niacin—atherosclerosis	0.000757	0.00715	CcSEcCtD
Perphenazine—Photosensitivity—Simvastatin—atherosclerosis	0.000754	0.00712	CcSEcCtD
Perphenazine—Gynaecomastia—Pravastatin—atherosclerosis	0.000738	0.00697	CcSEcCtD
Perphenazine—Eczema—Simvastatin—atherosclerosis	0.000737	0.00696	CcSEcCtD
Perphenazine—Muscular weakness—Rosuvastatin—atherosclerosis	0.000737	0.00696	CcSEcCtD
Perphenazine—Haemolytic anaemia—Simvastatin—atherosclerosis	0.000734	0.00693	CcSEcCtD
Perphenazine—Polyuria—Niacin—atherosclerosis	0.000693	0.00654	CcSEcCtD
Perphenazine—HTR2A—artery—atherosclerosis	0.000684	0.0229	CbGeAlD
Perphenazine—Photosensitivity—Pravastatin—atherosclerosis	0.000682	0.00644	CcSEcCtD
Perphenazine—Eczema—Niacin—atherosclerosis	0.000677	0.00639	CcSEcCtD
Perphenazine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000663	0.00626	CcSEcCtD
Perphenazine—Jaundice—Rosuvastatin—atherosclerosis	0.000628	0.00593	CcSEcCtD
Perphenazine—Muscular weakness—Ezetimibe—atherosclerosis	0.000613	0.00579	CcSEcCtD
Perphenazine—Eosinophilia—Lovastatin—atherosclerosis	0.000606	0.00572	CcSEcCtD
Perphenazine—Eosinophilia—Ezetimibe—atherosclerosis	0.000594	0.00561	CcSEcCtD
Perphenazine—Muscular weakness—Simvastatin—atherosclerosis	0.000584	0.00552	CcSEcCtD
Perphenazine—Urinary retention—Niacin—atherosclerosis	0.000578	0.00546	CcSEcCtD
Perphenazine—HTR2A—endothelium—atherosclerosis	0.000578	0.0193	CbGeAlD
Perphenazine—Eosinophilia—Simvastatin—atherosclerosis	0.000567	0.00535	CcSEcCtD
Perphenazine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000559	0.00528	CcSEcCtD
Perphenazine—Orthostatic hypotension—Niacin—atherosclerosis	0.000555	0.00525	CcSEcCtD
Perphenazine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000548	0.00517	CcSEcCtD
Perphenazine—CYP2C18—liver—atherosclerosis	0.000542	0.0181	CbGeAlD
Perphenazine—Muscular weakness—Niacin—atherosclerosis	0.000536	0.00507	CcSEcCtD
Perphenazine—HTR2A—blood vessel—atherosclerosis	0.000533	0.0178	CbGeAlD
Perphenazine—Cetirizine—HRH1—atherosclerosis	0.000529	0.102	CrCbGaD
Perphenazine—Muscular weakness—Pravastatin—atherosclerosis	0.000528	0.00499	CcSEcCtD
Perphenazine—Dysphagia—Niacin—atherosclerosis	0.000526	0.00496	CcSEcCtD
Perphenazine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000522	0.00493	CcSEcCtD
Perphenazine—Jaundice—Ezetimibe—atherosclerosis	0.000522	0.00493	CcSEcCtD
Perphenazine—Eosinophilia—Pravastatin—atherosclerosis	0.000512	0.00484	CcSEcCtD
Perphenazine—Jaundice—Simvastatin—atherosclerosis	0.000497	0.0047	CcSEcCtD
Perphenazine—AOX1—adipose tissue—atherosclerosis	0.000489	0.0163	CbGeAlD
Perphenazine—Oedema peripheral—Ezetimibe—atherosclerosis	0.000473	0.00447	CcSEcCtD
Perphenazine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000472	0.00446	CcSEcCtD
Perphenazine—Angioedema—Rosuvastatin—atherosclerosis	0.00046	0.00434	CcSEcCtD
Perphenazine—Aceprometazine—HRH1—atherosclerosis	0.000458	0.0886	CrCbGaD
Perphenazine—Jaundice—Niacin—atherosclerosis	0.000457	0.00431	CcSEcCtD
Perphenazine—CALM2—connective tissue—atherosclerosis	0.000451	0.0151	CbGeAlD
Perphenazine—Jaundice—Pravastatin—atherosclerosis	0.00045	0.00425	CcSEcCtD
Perphenazine—CALM1—connective tissue—atherosclerosis	0.000448	0.015	CbGeAlD
Perphenazine—CALM3—adipose tissue—atherosclerosis	0.00044	0.0147	CbGeAlD
Perphenazine—Cough—Rosuvastatin—atherosclerosis	0.000439	0.00415	CcSEcCtD
Perphenazine—HTR7—connective tissue—atherosclerosis	0.000438	0.0147	CbGeAlD
Perphenazine—Methdilazine—HRH1—atherosclerosis	0.000424	0.0821	CrCbGaD
Perphenazine—Hypoaesthesia—Niacin—atherosclerosis	0.000419	0.00395	CcSEcCtD
Perphenazine—Erythema—Ezetimibe—atherosclerosis	0.000418	0.00395	CcSEcCtD
Perphenazine—Oedema peripheral—Niacin—atherosclerosis	0.000414	0.00391	CcSEcCtD
Perphenazine—Confusional state—Rosuvastatin—atherosclerosis	0.000414	0.00391	CcSEcCtD
Perphenazine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000412	0.00389	CcSEcCtD
Perphenazine—Muscle spasms—Lovastatin—atherosclerosis	0.00041	0.00387	CcSEcCtD
Perphenazine—Infection—Rosuvastatin—atherosclerosis	0.000408	0.00385	CcSEcCtD
Perphenazine—Hydroxyzine—HRH1—atherosclerosis	0.000408	0.079	CrCbGaD
Perphenazine—Muscle spasms—Ezetimibe—atherosclerosis	0.000402	0.0038	CcSEcCtD
Perphenazine—Vision blurred—Lovastatin—atherosclerosis	0.000402	0.0038	CcSEcCtD
Perphenazine—HTR1A—cardiovascular system—atherosclerosis	0.000399	0.0133	CbGeAlD
Perphenazine—Erythema—Simvastatin—atherosclerosis	0.000399	0.00377	CcSEcCtD
Perphenazine—CALM2—cardiovascular system—atherosclerosis	0.000392	0.0131	CbGeAlD
Perphenazine—CALM1—cardiovascular system—atherosclerosis	0.00039	0.0131	CbGeAlD
Perphenazine—Angioedema—Lovastatin—atherosclerosis	0.00039	0.00368	CcSEcCtD
Perphenazine—Muscle spasms—Simvastatin—atherosclerosis	0.000383	0.00362	CcSEcCtD
Perphenazine—Angioedema—Ezetimibe—atherosclerosis	0.000382	0.00361	CcSEcCtD
Perphenazine—Leukopenia—Lovastatin—atherosclerosis	0.000382	0.0036	CcSEcCtD
Perphenazine—HTR7—cardiovascular system—atherosclerosis	0.000381	0.0127	CbGeAlD
Perphenazine—Vision blurred—Simvastatin—atherosclerosis	0.000376	0.00355	CcSEcCtD
Perphenazine—Insomnia—Rosuvastatin—atherosclerosis	0.000371	0.00351	CcSEcCtD
Perphenazine—Erythema—Niacin—atherosclerosis	0.000366	0.00346	CcSEcCtD
Perphenazine—Cough—Ezetimibe—atherosclerosis	0.000365	0.00345	CcSEcCtD
Perphenazine—Angioedema—Simvastatin—atherosclerosis	0.000364	0.00344	CcSEcCtD
Perphenazine—Hypertension—Ezetimibe—atherosclerosis	0.000361	0.00341	CcSEcCtD
Perphenazine—Leukopenia—Simvastatin—atherosclerosis	0.000357	0.00337	CcSEcCtD
Perphenazine—Dry mouth—Lovastatin—atherosclerosis	0.000355	0.00335	CcSEcCtD
Perphenazine—Muscle spasms—Niacin—atherosclerosis	0.000352	0.00333	CcSEcCtD
Perphenazine—Constipation—Rosuvastatin—atherosclerosis	0.000351	0.00332	CcSEcCtD
Perphenazine—Pain—Rosuvastatin—atherosclerosis	0.000351	0.00332	CcSEcCtD
Perphenazine—Confusional state—Lovastatin—atherosclerosis	0.000351	0.00331	CcSEcCtD
Perphenazine—Dry mouth—Ezetimibe—atherosclerosis	0.000348	0.00329	CcSEcCtD
Perphenazine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000348	0.00329	CcSEcCtD
Perphenazine—Muscle spasms—Pravastatin—atherosclerosis	0.000347	0.00327	CcSEcCtD
Perphenazine—Infection—Lovastatin—atherosclerosis	0.000346	0.00327	CcSEcCtD
Perphenazine—CALM2—adipose tissue—atherosclerosis	0.000346	0.0116	CbGeAlD
Perphenazine—Vision blurred—Niacin—atherosclerosis	0.000345	0.00326	CcSEcCtD
Perphenazine—Confusional state—Ezetimibe—atherosclerosis	0.000344	0.00325	CcSEcCtD
Perphenazine—CALM1—adipose tissue—atherosclerosis	0.000344	0.0115	CbGeAlD
Perphenazine—AOX1—liver—atherosclerosis	0.000343	0.0115	CbGeAlD
Perphenazine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000341	0.00322	CcSEcCtD
Perphenazine—Vision blurred—Pravastatin—atherosclerosis	0.00034	0.00321	CcSEcCtD
Perphenazine—Infection—Ezetimibe—atherosclerosis	0.000339	0.0032	CcSEcCtD
Perphenazine—Angioedema—Niacin—atherosclerosis	0.000335	0.00316	CcSEcCtD
Perphenazine—Anorexia—Lovastatin—atherosclerosis	0.000332	0.00313	CcSEcCtD
Perphenazine—Angioedema—Pravastatin—atherosclerosis	0.000329	0.00311	CcSEcCtD
Perphenazine—Syncope—Niacin—atherosclerosis	0.000328	0.0031	CcSEcCtD
Perphenazine—Confusional state—Simvastatin—atherosclerosis	0.000328	0.0031	CcSEcCtD
Perphenazine—Leukopenia—Niacin—atherosclerosis	0.000328	0.0031	CcSEcCtD
Perphenazine—HRH1—connective tissue—atherosclerosis	0.000327	0.0109	CbGeAlD
Perphenazine—Urticaria—Rosuvastatin—atherosclerosis	0.000326	0.00308	CcSEcCtD
Perphenazine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000326	0.00307	CcSEcCtD
Perphenazine—Infection—Simvastatin—atherosclerosis	0.000323	0.00305	CcSEcCtD
Perphenazine—Leukopenia—Pravastatin—atherosclerosis	0.000323	0.00305	CcSEcCtD
Perphenazine—Loss of consciousness—Niacin—atherosclerosis	0.000322	0.00304	CcSEcCtD
Perphenazine—ADRA2A—connective tissue—atherosclerosis	0.000321	0.0107	CbGeAlD
Perphenazine—Cough—Niacin—atherosclerosis	0.00032	0.00302	CcSEcCtD
Perphenazine—Insomnia—Lovastatin—atherosclerosis	0.000315	0.00297	CcSEcCtD
Perphenazine—Cough—Pravastatin—atherosclerosis	0.000315	0.00297	CcSEcCtD
Perphenazine—Hypertension—Pravastatin—atherosclerosis	0.000311	0.00294	CcSEcCtD
Perphenazine—Anorexia—Simvastatin—atherosclerosis	0.00031	0.00293	CcSEcCtD
Perphenazine—Dyspnoea—Lovastatin—atherosclerosis	0.00031	0.00293	CcSEcCtD
Perphenazine—Alimemazine—HRH1—atherosclerosis	0.000309	0.0599	CrCbGaD
Perphenazine—Insomnia—Ezetimibe—atherosclerosis	0.000309	0.00292	CcSEcCtD
Perphenazine—CALM3—liver—atherosclerosis	0.000309	0.0103	CbGeAlD
Perphenazine—Dry mouth—Niacin—atherosclerosis	0.000305	0.00288	CcSEcCtD
Perphenazine—Dyspnoea—Ezetimibe—atherosclerosis	0.000304	0.00287	CcSEcCtD
Perphenazine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000303	0.00286	CcSEcCtD
Perphenazine—Decreased appetite—Lovastatin—atherosclerosis	0.000303	0.00286	CcSEcCtD
Perphenazine—Anaphylactic shock—Niacin—atherosclerosis	0.000299	0.00282	CcSEcCtD
Perphenazine—Pain—Lovastatin—atherosclerosis	0.000298	0.00281	CcSEcCtD
Perphenazine—Constipation—Lovastatin—atherosclerosis	0.000298	0.00281	CcSEcCtD
Perphenazine—Confusional state—Pravastatin—atherosclerosis	0.000297	0.0028	CcSEcCtD
Perphenazine—Decreased appetite—Ezetimibe—atherosclerosis	0.000297	0.0028	CcSEcCtD
Perphenazine—Insomnia—Simvastatin—atherosclerosis	0.000294	0.00278	CcSEcCtD
Perphenazine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000294	0.00278	CcSEcCtD
Perphenazine—Shock—Niacin—atherosclerosis	0.000294	0.00278	CcSEcCtD
Perphenazine—Infection—Pravastatin—atherosclerosis	0.000292	0.00276	CcSEcCtD
Perphenazine—Pain—Ezetimibe—atherosclerosis	0.000292	0.00276	CcSEcCtD
Perphenazine—Constipation—Ezetimibe—atherosclerosis	0.000292	0.00276	CcSEcCtD
Perphenazine—Tachycardia—Niacin—atherosclerosis	0.000292	0.00276	CcSEcCtD
Perphenazine—CYP2B6—cardiovascular system—atherosclerosis	0.000291	0.00975	CbGeAlD
Perphenazine—Pruritus—Rosuvastatin—atherosclerosis	0.000291	0.00274	CcSEcCtD
Perphenazine—Dyspnoea—Simvastatin—atherosclerosis	0.00029	0.00274	CcSEcCtD
Perphenazine—CYP2C9—cardiovascular system—atherosclerosis	0.000289	0.00965	CbGeAlD
Perphenazine—Anorexia—Niacin—atherosclerosis	0.000285	0.00269	CcSEcCtD
Perphenazine—Decreased appetite—Simvastatin—atherosclerosis	0.000283	0.00267	CcSEcCtD
Perphenazine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000281	0.00265	CcSEcCtD
Perphenazine—Anorexia—Pravastatin—atherosclerosis	0.000281	0.00265	CcSEcCtD
Perphenazine—Hypotension—Niacin—atherosclerosis	0.000279	0.00264	CcSEcCtD
Perphenazine—Constipation—Simvastatin—atherosclerosis	0.000278	0.00263	CcSEcCtD
Perphenazine—Pain—Simvastatin—atherosclerosis	0.000278	0.00263	CcSEcCtD
Perphenazine—Urticaria—Lovastatin—atherosclerosis	0.000276	0.00261	CcSEcCtD
Perphenazine—Body temperature increased—Lovastatin—atherosclerosis	0.000275	0.0026	CcSEcCtD
Perphenazine—HTR2A—connective tissue—atherosclerosis	0.000273	0.00914	CbGeAlD
Perphenazine—Dizziness—Rosuvastatin—atherosclerosis	0.000272	0.00256	CcSEcCtD
Perphenazine—Urticaria—Ezetimibe—atherosclerosis	0.000271	0.00256	CcSEcCtD
Perphenazine—Insomnia—Niacin—atherosclerosis	0.00027	0.00255	CcSEcCtD
Perphenazine—Body temperature increased—Ezetimibe—atherosclerosis	0.00027	0.00255	CcSEcCtD
Perphenazine—Dyspnoea—Niacin—atherosclerosis	0.000266	0.00252	CcSEcCtD
Perphenazine—Insomnia—Pravastatin—atherosclerosis	0.000266	0.00251	CcSEcCtD
Perphenazine—Mequitazine—HRH1—atherosclerosis	0.000266	0.0515	CrCbGaD
Perphenazine—Somnolence—Niacin—atherosclerosis	0.000266	0.00251	CcSEcCtD
Perphenazine—Dyspnoea—Pravastatin—atherosclerosis	0.000262	0.00248	CcSEcCtD
Perphenazine—Decreased appetite—Niacin—atherosclerosis	0.00026	0.00245	CcSEcCtD
Perphenazine—Urticaria—Simvastatin—atherosclerosis	0.000259	0.00244	CcSEcCtD
Perphenazine—Body temperature increased—Simvastatin—atherosclerosis	0.000257	0.00243	CcSEcCtD
Perphenazine—Headache—Rosuvastatin—atherosclerosis	0.000257	0.00243	CcSEcCtD
Perphenazine—Hypersensitivity—Lovastatin—atherosclerosis	0.000256	0.00242	CcSEcCtD
Perphenazine—Decreased appetite—Pravastatin—atherosclerosis	0.000256	0.00242	CcSEcCtD
Perphenazine—Pain—Niacin—atherosclerosis	0.000256	0.00241	CcSEcCtD
Perphenazine—Constipation—Pravastatin—atherosclerosis	0.000252	0.00238	CcSEcCtD
Perphenazine—Pain—Pravastatin—atherosclerosis	0.000252	0.00238	CcSEcCtD
Perphenazine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000251	0.00238	CcSEcCtD
Perphenazine—HRH1—adipose tissue—atherosclerosis	0.000251	0.00839	CbGeAlD
Perphenazine—ADRA2A—adipose tissue—atherosclerosis	0.000247	0.00825	CbGeAlD
Perphenazine—Pruritus—Lovastatin—atherosclerosis	0.000246	0.00233	CcSEcCtD
Perphenazine—CALM2—liver—atherosclerosis	0.000242	0.00811	CbGeAlD
Perphenazine—Pruritus—Ezetimibe—atherosclerosis	0.000241	0.00228	CcSEcCtD
Perphenazine—CALM1—liver—atherosclerosis	0.000241	0.00807	CbGeAlD
Perphenazine—Hypersensitivity—Simvastatin—atherosclerosis	0.00024	0.00227	CcSEcCtD
Perphenazine—Diarrhoea—Lovastatin—atherosclerosis	0.000238	0.00225	CcSEcCtD
Perphenazine—HTR2A—cardiovascular system—atherosclerosis	0.000238	0.00795	CbGeAlD
Perphenazine—Urticaria—Niacin—atherosclerosis	0.000237	0.00224	CcSEcCtD
Perphenazine—Body temperature increased—Niacin—atherosclerosis	0.000236	0.00223	CcSEcCtD
Perphenazine—HTR7—liver—atherosclerosis	0.000236	0.00788	CbGeAlD
Perphenazine—Urticaria—Pravastatin—atherosclerosis	0.000234	0.00221	CcSEcCtD
Perphenazine—Diarrhoea—Ezetimibe—atherosclerosis	0.000234	0.00221	CcSEcCtD
Perphenazine—Body temperature increased—Pravastatin—atherosclerosis	0.000233	0.0022	CcSEcCtD
Perphenazine—Pruritus—Simvastatin—atherosclerosis	0.00023	0.00218	CcSEcCtD
Perphenazine—CYP2C19—liver—atherosclerosis	0.00023	0.0077	CbGeAlD
Perphenazine—Dizziness—Lovastatin—atherosclerosis	0.00023	0.00217	CcSEcCtD
Perphenazine—Dizziness—Ezetimibe—atherosclerosis	0.000226	0.00213	CcSEcCtD
Perphenazine—Diarrhoea—Simvastatin—atherosclerosis	0.000223	0.0021	CcSEcCtD
Perphenazine—Hypersensitivity—Niacin—atherosclerosis	0.00022	0.00208	CcSEcCtD
Perphenazine—Zuclopenthixol—HRH1—atherosclerosis	0.00022	0.0425	CrCbGaD
Perphenazine—Headache—Lovastatin—atherosclerosis	0.000218	0.00206	CcSEcCtD
Perphenazine—Hypersensitivity—Pravastatin—atherosclerosis	0.000217	0.00205	CcSEcCtD
Perphenazine—Dizziness—Simvastatin—atherosclerosis	0.000215	0.00203	CcSEcCtD
Perphenazine—Headache—Ezetimibe—atherosclerosis	0.000214	0.00202	CcSEcCtD
Perphenazine—Pruritus—Niacin—atherosclerosis	0.000211	0.002	CcSEcCtD
Perphenazine—Pruritus—Pravastatin—atherosclerosis	0.000208	0.00197	CcSEcCtD
Perphenazine—Diarrhoea—Niacin—atherosclerosis	0.000205	0.00193	CcSEcCtD
Perphenazine—Headache—Simvastatin—atherosclerosis	0.000204	0.00193	CcSEcCtD
Perphenazine—Aripiprazole—HRH1—atherosclerosis	0.000203	0.0393	CrCbGaD
Perphenazine—Trazodone—HRH1—atherosclerosis	0.000202	0.0391	CrCbGaD
Perphenazine—Diarrhoea—Pravastatin—atherosclerosis	0.000201	0.0019	CcSEcCtD
Perphenazine—CYP2C8—liver—atherosclerosis	0.000201	0.00672	CbGeAlD
Perphenazine—Dizziness—Niacin—atherosclerosis	0.000198	0.00187	CcSEcCtD
Perphenazine—Dizziness—Pravastatin—atherosclerosis	0.000195	0.00184	CcSEcCtD
Perphenazine—Thiothixene—HRH1—atherosclerosis	0.000189	0.0367	CrCbGaD
Perphenazine—CYP1A2—liver—atherosclerosis	0.000188	0.00629	CbGeAlD
Perphenazine—Headache—Niacin—atherosclerosis	0.000187	0.00177	CcSEcCtD
Perphenazine—Mesoridazine—HRH1—atherosclerosis	0.000187	0.0362	CrCbGaD
Perphenazine—Headache—Pravastatin—atherosclerosis	0.000184	0.00174	CcSEcCtD
Perphenazine—Prochlorperazine—HRH1—atherosclerosis	0.000181	0.035	CrCbGaD
Perphenazine—CYP2B6—liver—atherosclerosis	0.00018	0.00603	CbGeAlD
Perphenazine—CYP2C9—liver—atherosclerosis	0.000178	0.00597	CbGeAlD
Perphenazine—Fluphenazine—HRH1—atherosclerosis	0.000164	0.0317	CrCbGaD
Perphenazine—Propiomazine—HRH1—atherosclerosis	0.000157	0.0305	CrCbGaD
Perphenazine—Chlorprothixene—HRH1—atherosclerosis	0.000149	0.0288	CrCbGaD
Perphenazine—HTR2A—liver—atherosclerosis	0.000147	0.00492	CbGeAlD
Perphenazine—Thioridazine—HRH1—atherosclerosis	0.000141	0.0273	CrCbGaD
Perphenazine—CYP3A4—liver—atherosclerosis	0.000136	0.00455	CbGeAlD
Perphenazine—Methotrimeprazine—HRH1—atherosclerosis	0.000135	0.0261	CrCbGaD
Perphenazine—CYP2D6—liver—atherosclerosis	0.000134	0.00448	CbGeAlD
Perphenazine—Promethazine—HRH1—atherosclerosis	0.000133	0.0257	CrCbGaD
Perphenazine—Trifluoperazine—HRH1—atherosclerosis	0.000131	0.0253	CrCbGaD
Perphenazine—Quetiapine—HRH1—atherosclerosis	0.000127	0.0246	CrCbGaD
Perphenazine—Promazine—HRH1—atherosclerosis	0.000117	0.0226	CrCbGaD
Perphenazine—Chlorpromazine—HRH1—atherosclerosis	0.000103	0.0199	CrCbGaD
Perphenazine—Acepromazine—ALB—atherosclerosis	4.55e-05	0.0088	CrCbGaD
Perphenazine—Thioproperazine—ALB—atherosclerosis	4.44e-05	0.0086	CrCbGaD
Perphenazine—Pipotiazine—ALB—atherosclerosis	4.37e-05	0.00846	CrCbGaD
Perphenazine—Thiothixene—ALB—atherosclerosis	4.37e-05	0.00846	CrCbGaD
Perphenazine—Clomipramine—ALB—atherosclerosis	3.45e-05	0.00669	CrCbGaD
Perphenazine—Chlorpromazine—ALB—atherosclerosis	2.37e-05	0.00459	CrCbGaD
Perphenazine—CALM2—Immune System—MAPK8—atherosclerosis	2.76e-06	2.61e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CG—atherosclerosis	2.75e-06	2.61e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CG—atherosclerosis	2.75e-06	2.61e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AGT—atherosclerosis	2.75e-06	2.61e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—NOS3—atherosclerosis	2.73e-06	2.59e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—NOS3—atherosclerosis	2.73e-06	2.59e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—STAT3—atherosclerosis	2.73e-06	2.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—MAPK3—atherosclerosis	2.73e-06	2.58e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AGT—atherosclerosis	2.73e-06	2.58e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—LPL—atherosclerosis	2.72e-06	2.58e-05	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—AKT1—atherosclerosis	2.71e-06	2.57e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	2.71e-06	2.57e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—INS—atherosclerosis	2.69e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—APOE—atherosclerosis	2.69e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—AKT1—atherosclerosis	2.68e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—AKT1—atherosclerosis	2.68e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.68e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—APOE—atherosclerosis	2.67e-06	2.53e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CAV1—atherosclerosis	2.67e-06	2.53e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—APOA1—atherosclerosis	2.66e-06	2.52e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GPX1—atherosclerosis	2.66e-06	2.52e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—atherosclerosis	2.66e-06	2.52e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCL2—atherosclerosis	2.65e-06	2.51e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CAV1—atherosclerosis	2.65e-06	2.51e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.64e-06	2.51e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	2.64e-06	2.51e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—APOA1—atherosclerosis	2.64e-06	2.5e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—MAPK3—atherosclerosis	2.64e-06	2.5e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—MAPK3—atherosclerosis	2.64e-06	2.5e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	2.63e-06	2.49e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.62e-06	2.48e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	2.61e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—STAT3—atherosclerosis	2.61e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—INS—atherosclerosis	2.61e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—INS—atherosclerosis	2.61e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IGF1—atherosclerosis	2.61e-06	2.47e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	2.6e-06	2.47e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	2.59e-06	2.45e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CD36—atherosclerosis	2.59e-06	2.45e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—atherosclerosis	2.58e-06	2.45e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.57e-06	2.44e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ALB—atherosclerosis	2.57e-06	2.44e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.57e-06	2.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL2—atherosclerosis	2.56e-06	2.43e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL2—atherosclerosis	2.56e-06	2.43e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.56e-06	2.43e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	2.56e-06	2.42e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PPARG—atherosclerosis	2.55e-06	2.42e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	2.55e-06	2.42e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	2.53e-06	2.4e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	2.52e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—STAT3—atherosclerosis	2.52e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—STAT3—atherosclerosis	2.52e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IGF1—atherosclerosis	2.52e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IGF1—atherosclerosis	2.52e-06	2.39e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	2.52e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—INS—atherosclerosis	2.5e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—atherosclerosis	2.5e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—atherosclerosis	2.5e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—MAPK3—atherosclerosis	2.49e-06	2.36e-05	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	2.48e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SERPINE1—atherosclerosis	2.47e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—NOS3—atherosclerosis	2.46e-06	2.33e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.45e-06	2.32e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL6—atherosclerosis	2.44e-06	2.31e-05	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	2.44e-06	2.31e-05	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	2.43e-06	2.31e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.43e-06	2.3e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.41e-06	2.28e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—MAPK3—atherosclerosis	2.41e-06	2.28e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—MAPK3—atherosclerosis	2.41e-06	2.28e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—STAT3—atherosclerosis	2.41e-06	2.28e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARA—atherosclerosis	2.4e-06	2.28e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	2.4e-06	2.28e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL6—atherosclerosis	2.4e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SERPINE1—atherosclerosis	2.39e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SERPINE1—atherosclerosis	2.39e-06	2.27e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	2.37e-06	2.25e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NOS3—atherosclerosis	2.36e-06	2.24e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	2.36e-06	2.24e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	2.35e-06	2.23e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PPARG—atherosclerosis	2.35e-06	2.22e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	2.34e-06	2.22e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AGT—atherosclerosis	2.33e-06	2.21e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—STAT3—atherosclerosis	2.33e-06	2.21e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—STAT3—atherosclerosis	2.33e-06	2.21e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PPARG—atherosclerosis	2.33e-06	2.2e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP9—atherosclerosis	2.32e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—INS—atherosclerosis	2.3e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MAPK3—atherosclerosis	2.3e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.3e-06	2.18e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	2.3e-06	2.18e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	2.3e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ALB—atherosclerosis	2.29e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NOS3—atherosclerosis	2.29e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NOS3—atherosclerosis	2.29e-06	2.17e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	2.28e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOE—atherosclerosis	2.28e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—INS—atherosclerosis	2.28e-06	2.16e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—atherosclerosis	2.28e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CAV1—atherosclerosis	2.26e-06	2.14e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	2.26e-06	2.14e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.26e-06	2.14e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOA1—atherosclerosis	2.26e-06	2.14e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	2.25e-06	2.14e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.25e-06	2.13e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.25e-06	2.13e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	2.25e-06	2.13e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	2.23e-06	2.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—atherosclerosis	2.23e-06	2.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MAPK3—atherosclerosis	2.22e-06	2.11e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MAPK3—atherosclerosis	2.22e-06	2.11e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	2.22e-06	2.11e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	2.22e-06	2.1e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—atherosclerosis	2.22e-06	2.1e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	2.22e-06	2.1e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—atherosclerosis	2.22e-06	2.1e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	2.21e-06	2.1e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	2.21e-06	2.09e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOB—atherosclerosis	2.2e-06	2.09e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—NOS3—atherosclerosis	2.19e-06	2.08e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	2.18e-06	2.07e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	2.18e-06	2.06e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	2.17e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—atherosclerosis	2.16e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—atherosclerosis	2.16e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.14e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—atherosclerosis	2.11e-06	2e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—LPL—atherosclerosis	2.1e-06	1.99e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—atherosclerosis	2.1e-06	1.99e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—atherosclerosis	2.09e-06	1.98e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2.08e-06	1.98e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	2.08e-06	1.97e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—atherosclerosis	2.06e-06	1.96e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.06e-06	1.95e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	2.06e-06	1.95e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	2.05e-06	1.94e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.05e-06	1.94e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	2.05e-06	1.94e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—atherosclerosis	2.05e-06	1.94e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—atherosclerosis	2.04e-06	1.94e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	2.03e-06	1.92e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—atherosclerosis	2.03e-06	1.92e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—atherosclerosis	2.03e-06	1.92e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—atherosclerosis	2.03e-06	1.92e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	2.02e-06	1.92e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.02e-06	1.91e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	2.01e-06	1.91e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.01e-06	1.9e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—NOS3—atherosclerosis	2e-06	1.9e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CD36—atherosclerosis	2e-06	1.89e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—atherosclerosis	1.99e-06	1.89e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—atherosclerosis	1.99e-06	1.88e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	1.97e-06	1.87e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—INS—atherosclerosis	1.95e-06	1.85e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	1.94e-06	1.84e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	1.94e-06	1.83e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—atherosclerosis	1.93e-06	1.83e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—atherosclerosis	1.93e-06	1.83e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.91e-06	1.81e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—atherosclerosis	1.91e-06	1.81e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—atherosclerosis	1.9e-06	1.8e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.89e-06	1.79e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	1.88e-06	1.78e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	1.88e-06	1.78e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NFKB1—atherosclerosis	1.88e-06	1.78e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.87e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARA—atherosclerosis	1.86e-06	1.76e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.85e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.85e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK8—atherosclerosis	1.84e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—atherosclerosis	1.84e-06	1.74e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—atherosclerosis	1.83e-06	1.74e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—atherosclerosis	1.83e-06	1.74e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.83e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—atherosclerosis	1.82e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NFKB1—atherosclerosis	1.81e-06	1.72e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NFKB1—atherosclerosis	1.81e-06	1.72e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AGT—atherosclerosis	1.8e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—atherosclerosis	1.79e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK8—atherosclerosis	1.78e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK8—atherosclerosis	1.78e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—atherosclerosis	1.78e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—atherosclerosis	1.78e-06	1.69e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.76e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—atherosclerosis	1.76e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—atherosclerosis	1.76e-06	1.67e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—atherosclerosis	1.76e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOE—atherosclerosis	1.76e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.74e-06	1.65e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.74e-06	1.65e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.71e-06	1.62e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—NOS3—atherosclerosis	1.71e-06	1.62e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—atherosclerosis	1.7e-06	1.61e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—atherosclerosis	1.69e-06	1.6e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—atherosclerosis	1.68e-06	1.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—atherosclerosis	1.68e-06	1.59e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—atherosclerosis	1.65e-06	1.56e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—atherosclerosis	1.65e-06	1.56e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.64e-06	1.56e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—atherosclerosis	1.63e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—atherosclerosis	1.63e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—atherosclerosis	1.63e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—atherosclerosis	1.63e-06	1.54e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—atherosclerosis	1.63e-06	1.54e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—atherosclerosis	1.62e-06	1.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—atherosclerosis	1.62e-06	1.54e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK3—atherosclerosis	1.61e-06	1.53e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.59e-06	1.51e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.56e-06	1.48e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—atherosclerosis	1.56e-06	1.48e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK3—atherosclerosis	1.56e-06	1.48e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK3—atherosclerosis	1.56e-06	1.48e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—atherosclerosis	1.55e-06	1.47e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.53e-06	1.45e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.51e-06	1.44e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—atherosclerosis	1.51e-06	1.43e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—atherosclerosis	1.51e-06	1.43e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	1.51e-06	1.43e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—INS—atherosclerosis	1.5e-06	1.43e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—atherosclerosis	1.5e-06	1.42e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—atherosclerosis	1.5e-06	1.42e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—atherosclerosis	1.44e-06	1.37e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—atherosclerosis	1.42e-06	1.35e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.42e-06	1.34e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—atherosclerosis	1.42e-06	1.34e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—atherosclerosis	1.38e-06	1.31e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—atherosclerosis	1.33e-06	1.26e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.33e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.32e-06	1.25e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.31e-06	1.24e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.31e-06	1.24e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—atherosclerosis	1.3e-06	1.23e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.29e-06	1.22e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—atherosclerosis	1.26e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—atherosclerosis	1.26e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.21e-06	1.14e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.19e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—atherosclerosis	1.18e-06	1.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—atherosclerosis	1.14e-06	1.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—atherosclerosis	1.14e-06	1.08e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.13e-06	1.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—atherosclerosis	1.09e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—atherosclerosis	1.05e-06	9.96e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—atherosclerosis	1.05e-06	9.96e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.01e-06	9.56e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—atherosclerosis	9.28e-07	8.79e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—atherosclerosis	9.2e-07	8.72e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—atherosclerosis	7.86e-07	7.45e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—atherosclerosis	6.06e-07	5.75e-06	CbGpPWpGaD
